Viewing Study NCT00579592


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-02-20 @ 3:38 PM
Study NCT ID: NCT00579592
Status: TERMINATED
Last Update Posted: 2012-06-26
First Post: 2007-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation
Sponsor: University of Wisconsin, Madison
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-04
Start Date Type: None
Primary Completion Date: 2007-03
Primary Completion Date Type: ACTUAL
Completion Date: 2007-04
Completion Date Type: ACTUAL
First Submit Date: 2007-12-17
First Submit QC Date: None
Study First Post Date: 2007-12-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-06-22
Last Update Post Date: 2012-06-26
Last Update Post Date Type: ESTIMATED